Clin2
NCT06735612Likely a fitRecruiting

RSV and COPD Flare-Ups Study

Respiratory Synctial VirusCOPDChronic Obstructive Pulmonary Disease (COPD)Exacerbation of COPD

Part of Lungs & breathing clinical trials.

This study looks at whether RSV (a common respiratory virus) is linked to COPD flare-ups that need urgent care. By testing patients during a flare-up, researchers hope to understand how RSV affects COPD and find better ways to manage it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
892 people
Ages
50 years and older
Study type
Observational

Who can take part

  • You are 50 years old or older.
  • You are currently seeking urgent medical care for a sudden worsening of COPD symptoms (like shortness of breath, cough, or mucus) that started within the last 2 weeks.
  • You have not received a vaccine for RSV (respiratory syncytial virus) before.
  • You do not have an active cancer or any other condition that might affect your immune system.
  • You do not have a neurological disorder that would prevent you from participating.
  • You are willing and able to sign a consent form to take part in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07508644Not yet recruiting· Phase 4
RSV vaccine to prevent COPD flare-ups

This trial tests whether the RSV vaccine can reduce repeated COPD flare-ups. You may qualify if you are 50+, have COPD, smoke or used to smoke, and have had frequent flare-ups while on a recommended dual inhaler.

Shatin
NCT07112235Recruiting
COPD and cold virus study

This study looks at how the common cold virus affects people with COPD to find new treatments. If you have moderate COPD and your symptoms flare up when you catch a cold, you may be able to help.

London
NCT07713628Not yet recruiting
RSV B infection study in healthy older adults

This study will safely expose healthy older adults (65-75) to a mild RSV B virus to see how their immune system responds. It may help develop better vaccines or treatments for RSV in older people.

NCT07653100Recruiting· Phase 3
RSV vaccine study for adults with chronic conditions

This study tests an RSV vaccine in adults aged 18 and older, especially those with chronic health issues like heart or lung disease. It aims to see how safe and effective the vaccine is at preventing RSV infections.

Visakhapatnam, Andhra Pradesh
NCT06197152Recruiting
RSV severity markers in hospitalized adults

This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.

Créteil
NCT06105814Not yet recruiting
Improving diagnosis and care for COPD flare-ups

This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.

Hear when a new Respiratory Synctial Virus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.